PTC Therapeutics, Inc. (PTCT) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "PTCT"
      ],
      "issuer_cik": "0001070081",
      "owner_cik": "0001288952",
      "accession_number": "0001288952-26-000016",
      "form_type": "4",
      "filing_date": "2026-10-16",
      "period_of_report": "2026-10-14",
      "issuer_name": "PTC THERAPEUTICS, INC.",
      "issuer_trading_symbol": "PTCT",
      "owner_name": "SCHMERTZLER MICHAEL",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-14",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 382,
      "transaction_price_per_share": 60.14,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 1291594,
      "transaction_value": 22973.48,
      "direct_or_indirect": "I",
      "nature_of_ownership": "See footnote",
      "footnotes": [
        {
          "id": "F1",
          "description": "This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by Section Six Partners, L.P., of which the Reporting Person is a general partner and limited partner, on May 14, 2026."
        },
        {
          "id": "F4",
          "description": "This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.87 to $60.54 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."
        },
        {
          "id": "F3",
          "description": "Represents shares of common stock held by Section Six Partners, L.P. The Reporting Person is a general and limited partner of Section Six Partners, L.P. The Reporting Person disclaims beneficial ownership of the shares of common stock held by Section Six Partners, L.P. except to the extent of his pecuniary interest therein."
        }
      ]
    },
    {
      "tickers": [
        "PTCT"
      ],
      "issuer_cik": "0001070081",
      "owner_cik": "0001288952",
      "accession_number": "0001288952-26-000016",
      "form_type": "4",
      "filing_date": "2026-10-16",
      "period_of_report": "2026-10-14",
      "issuer_name": "PTC THERAPEUTICS, INC.",
      "issuer_trading_symbol": "PTCT",
      "owner_name": "SCHMERTZLER MICHAEL",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-14",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 2118,
      "transaction_price_per_share": 59.52,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 1291976,
      "transaction_value": 126063.36,
      "direct_or_indirect": "I",
      "nature_of_ownership": "See footnote",
      "footnotes": [
        {
          "id": "F1",
          "description": "This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by Section Six Partners, L.P., of which the Reporting Person is a general partner and limited partner, on May 14, 2026."
        },
        {
          "id": "F2",
          "description": "This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.85 to $59.82 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."
        },
        {
          "id": "F3",
          "description": "Represents shares of common stock held by Section Six Partners, L.P. The Reporting Person is a general and limited partner of Section Six Partners, L.P. The Reporting Person disclaims beneficial ownership of the shares of common stock held by Section Six Partners, L.P. except to the extent of his pecuniary interest therein."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.